Innovative laser system

Article

Schwind product profile.

SCHWIND has announced the addition of the new flagship system to the company's excimer laser portfolio, the SCHWIND AMARIS 1050RS.

This innovative laser system operates at a repetition rate of 1050 Hz, which enables an extremely short ablation time of just 1.3 seconds per dioptre (myopia, without astigmatism, 12.5 mm vertex distance and 6 mm optical zone). According to the company, this leads to greater safety and patient comfort.

Additionally, it is reported that this system shortens the length of exposure time for the corneal stroma, minimizing the risk of drying out. Also, the length of time that the patient is required to fixate on the green light is reduced. Further to this, the new system incorporates Intelligent Thermal Effect Control that protects the tissue from thermal damage.

The company states that another innovative feature of AMARIS 1050RS is the active 7 D eye tracking in space and time. This Latency-Free Tracking enables anticipation and pre-compensation of eye movements during the period between acquisition of the eyetracker image and triggering of the subsequent laser pulses - resulting in zero latency and greater safety.

Company name: SCHWIND eye-tech-solutions GmbH & Co. KG
Telephone: +49 (0) 60 27/5 08-164
E-mail: antje.splittdorf@eye-tech.netWebsite: www.eye-tech-solutions.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.